By Sahil Pandey and Puyaan Singh April 14 (Reuters) - Amazon's cloud unit on Tuesday launched Amazon Bio Discovery, an ...

Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, GPT-Rosalind, to ...

Amazon has already collaborated with Memorial Sloan Kettering Cancer Center with its AI software.

OpenAI has released GPT-Rosalind, a large language model fine-tuned specifically for life sciences research, marking the ...

Inventia Life Science today announced the launch of RASTRUM™ Validated Solutions, a new product offering designed to help drug discovery teams generate decision-grade data from human-relevant 3D cell ...

Former Disney and Discovery LatAm exec Carolina Lightcap has partnered with three other industry vets to launch ShowUp ...

AWS's new AI platform grants researchers direct access to a broad library of biological foundation models for lab-in-the-loop drug discovery.

SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform.

Starbucks is trying to find ways to entice U.S. customers back to its cafes.

Amazon has pitched an AI-powered drug discovery platform to the biopharma industry that it says brings together computational ...